A detailed history of Squarepoint Ops LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 13,318 shares of ABCL stock, worth $38,888. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,318
Previous 68,908 80.67%
Holding current value
$38,888
Previous $203,000 83.25%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.39 - $3.49 $132,860 - $194,009
-55,590 Reduced 80.67%
13,318 $34,000
Q2 2024

Aug 14, 2024

BUY
$2.73 - $4.73 $60,420 - $104,684
22,132 Added 47.31%
68,908 $203,000
Q1 2024

May 15, 2024

SELL
$4.29 - $5.97 $22,440 - $31,229
-5,231 Reduced 10.06%
46,776 $211,000
Q4 2023

Feb 14, 2024

SELL
$3.91 - $5.93 $283,009 - $429,219
-72,381 Reduced 58.19%
52,007 $296,000
Q2 2023

Aug 14, 2023

SELL
$5.66 - $7.59 $192,660 - $258,356
-34,039 Reduced 21.49%
124,388 $803,000
Q1 2023

May 15, 2023

SELL
$7.31 - $11.18 $286,149 - $437,641
-39,145 Reduced 19.81%
158,427 $1.19 Million
Q4 2022

Feb 14, 2023

BUY
$9.48 - $14.52 $1.41 Million - $2.16 Million
148,779 Added 304.92%
197,572 $2 Million
Q3 2022

Nov 14, 2022

SELL
$9.2 - $13.68 $695,244 - $1.03 Million
-75,570 Reduced 60.77%
48,793 $483,000
Q2 2022

Aug 15, 2022

SELL
$5.72 - $10.65 $357,191 - $665,049
-62,446 Reduced 33.43%
124,363 $1.32 Million
Q1 2022

May 16, 2022

BUY
$7.46 - $14.14 $794,698 - $1.51 Million
106,528 Added 132.69%
186,809 $1.82 Million
Q4 2021

Feb 14, 2022

BUY
$12.99 - $17.73 $308,460 - $421,016
23,746 Added 42.0%
80,281 $1.15 Million
Q3 2021

Nov 15, 2021

BUY
$14.85 - $21.34 $492,886 - $708,295
33,191 Added 142.18%
56,535 $1.13 Million
Q2 2021

Aug 16, 2021

BUY
$20.19 - $34.17 $155,119 - $262,528
7,683 Added 49.06%
23,344 $514,000
Q1 2021

May 17, 2021

BUY
$23.29 - $53.2 $364,744 - $833,165
15,661 New
15,661 $532,000

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $833M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.